{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihaqikjyrp7ha7si3ggv3pghvye752y52ufarmmflog6jik6764ou",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjiyo6oju472"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib2kyf5ypao5zrxbtjrjoldrjhliqx3ckv7tk5fizp2xrdl5doo4a"
    },
    "mimeType": "image/jpeg",
    "size": 413830
  },
  "path": "/news/2026-04-primary-campaign-benzodiazepine-overuse-patient.html",
  "publishedAt": "2026-04-14T22:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The widespread use of benzodiazepines—better known as sleeping pills or anxiety medication—among the population has become a serious public health issue. These psychotropic drugs, central nervous system depressants prescribed to treat anxiety and insomnia, carry a high risk of dependence, cognitive impairment and falls, among other consequences. A 2024 study carried out by the Spanish Organization of Consumers and Users (OCU) showed that 22% of the Spanish population regularly use this type of medication, in four out of ten cases on a daily basis.",
  "title": "New primary care campaign seeks to cut benzodiazepine overuse with reviews and patient support"
}